Rituximab in relapsing and progressive forms of multiple sclerosis: a systematic review.
<h4>Background</h4>Rituximab is an anti-CD20 monoclonal antibody approved for non Hodgkin lymphoma and rheumatoid arthritis. It is being considered for the treatment of MS.<h4>Objectives</h4>To evaluate the efficacy and safety of rituximab for MS treatment.<h4>Data coll...
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2013-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0066308&type=printable |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|